SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-149895
Filing Date
2024-05-30
Accepted
2024-05-30 08:35:47
Documents
54
Period of Report
2024-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834662d8k.htm   iXBRL 8-K 30145
2 EX-99.1 d834662dex991.htm EX-99.1 7974
3 EX-99.2 d834662dex992.htm EX-99.2 51469
7 GRAPHIC g834662ex99_2p10g1.jpg GRAPHIC 274691
8 GRAPHIC g834662ex99_2p11g1.jpg GRAPHIC 242680
9 GRAPHIC g834662ex99_2p12g1.jpg GRAPHIC 253557
10 GRAPHIC g834662ex99_2p13g1.jpg GRAPHIC 478805
11 GRAPHIC g834662ex99_2p14g1.jpg GRAPHIC 207738
12 GRAPHIC g834662ex99_2p15g1.jpg GRAPHIC 246182
13 GRAPHIC g834662ex99_2p16g1.jpg GRAPHIC 248819
14 GRAPHIC g834662ex99_2p17g1.jpg GRAPHIC 249736
15 GRAPHIC g834662ex99_2p18g1.jpg GRAPHIC 230620
16 GRAPHIC g834662ex99_2p19g1.jpg GRAPHIC 234347
17 GRAPHIC g834662ex99_2p1g1.jpg GRAPHIC 276215
18 GRAPHIC g834662ex99_2p20g1.jpg GRAPHIC 298644
19 GRAPHIC g834662ex99_2p21g1.jpg GRAPHIC 239285
20 GRAPHIC g834662ex99_2p22g1.jpg GRAPHIC 398305
21 GRAPHIC g834662ex99_2p23g1.jpg GRAPHIC 344172
22 GRAPHIC g834662ex99_2p24g1.jpg GRAPHIC 279660
23 GRAPHIC g834662ex99_2p25g1.jpg GRAPHIC 60679
24 GRAPHIC g834662ex99_2p26g1.jpg GRAPHIC 284153
25 GRAPHIC g834662ex99_2p27g1.jpg GRAPHIC 299907
26 GRAPHIC g834662ex99_2p28g1.jpg GRAPHIC 378716
27 GRAPHIC g834662ex99_2p29g1.jpg GRAPHIC 263108
28 GRAPHIC g834662ex99_2p2g1.jpg GRAPHIC 480277
29 GRAPHIC g834662ex99_2p30g1.jpg GRAPHIC 330067
30 GRAPHIC g834662ex99_2p31g1.jpg GRAPHIC 326985
31 GRAPHIC g834662ex99_2p32g1.jpg GRAPHIC 236989
32 GRAPHIC g834662ex99_2p33g1.jpg GRAPHIC 325996
33 GRAPHIC g834662ex99_2p34g1.jpg GRAPHIC 254622
34 GRAPHIC g834662ex99_2p35g1.jpg GRAPHIC 244256
35 GRAPHIC g834662ex99_2p36g1.jpg GRAPHIC 253778
36 GRAPHIC g834662ex99_2p37g1.jpg GRAPHIC 303458
37 GRAPHIC g834662ex99_2p38g1.jpg GRAPHIC 326330
38 GRAPHIC g834662ex99_2p3g1.jpg GRAPHIC 365752
39 GRAPHIC g834662ex99_2p4g1.jpg GRAPHIC 224669
40 GRAPHIC g834662ex99_2p5g1.jpg GRAPHIC 266131
41 GRAPHIC g834662ex99_2p6g1.jpg GRAPHIC 215730
42 GRAPHIC g834662ex99_2p7g1.jpg GRAPHIC 391441
43 GRAPHIC g834662ex99_2p8g1.jpg GRAPHIC 269505
44 GRAPHIC g834662ex99_2p9g1.jpg GRAPHIC 375521
45 GRAPHIC g834662g66y20.gif GRAPHIC 5763
  Complete submission text file 0001193125-24-149895.txt   15375850

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dawn-20240529.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20240529_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20240529_pre.xml EX-101.PRE 11266
57 EXTRACTED XBRL INSTANCE DOCUMENT d834662d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 241000840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)